Filing Details

Accession Number:
0001209191-19-012005
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-21 16:26:09
Reporting Period:
2019-02-19
Accepted Time:
2019-02-21 16:26:09
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1661567 Michael Parini 50 Northern Avenue
Boston MA 02210
Evp, Cl&Ao No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-02-19 4,624 $186.79 36,003 No 4 S Direct
Common Stock Disposition 2019-02-19 600 $187.42 35,403 No 4 S Direct
Common Stock Disposition 2019-02-19 400 $188.54 35,003 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
  2. Open market sales reported on this line occurred at a weighted average price of $186.79 (range $186.09 to $187.05).
  3. Mr. Parini undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
  4. Open market sales reported on this line occurred at a weighted average price of $187.42 (range $187.12 to $187.96).
  5. Open market sales reported on this line occurred at a weighted average price of $188.54 (range $188.36 to $188.85).